| First Author | Bednar I | Year | 2002 |
| Journal | Mol Cell Neurosci | Volume | 20 |
| Issue | 2 | Pages | 354-65 |
| PubMed ID | 12093166 | Mgi Jnum | J:77466 |
| Mgi Id | MGI:2181836 | Doi | 10.1006/mcne.2002.1112 |
| Citation | Bednar I, et al. (2002) Selective Nicotinic Receptor Consequences in APP(SWE) Transgenic Mice. Mol Cell Neurosci 20(2):354-65 |
| abstractText | The nicotinic (nAChRs) and muscarinic (mAChRs) acetylcholine receptors and acetylcholinesterase (AChE) activity were studied in the brains of APP(SWE) transgenic mice (Tg+) and age-matched nontransgenic controls (Tg-) that were between 4 and 19 months of age. A significant increase in the binding of (125)I-labeled alpha-bungarotoxin (alpha7 nAChRs) was observed in most brain regions analyzed in 4-month-old Tg+ mice, preceding learning and memory impairments and amyloid-beta (Abeta) pathology. The enhanced alpha7 receptor binding was still detectable at 17-19 months of age. Increase in [(3)H]cytisine binding (alpha4beta2 nAChRs) was measured at 17-19 months of age in Tg+ mice, at the same age when the animals showed heavy Abeta pathology. No significant changes in [(3)H]pirenzepine (M1 mAChRs) or [(3)H]AFDX 384 (M2 mAChRs) binding sites were found at any age studied. The upregulation of the nAChRs probably reflects compensatory mechanisms in response to Abeta burden in the brains of Tg+ mice. (c) 2002 Elsevier Science (USA). |
